These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 21269977
1. [Oxidation status and γ-glutamylcysteine synthetase expression in the kidney of MRL/lpr lupus mice]. Chen RL, Tao Y, Zhang BP, Lv ZF. Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):138-40. PubMed ID: 21269977 [Abstract] [Full Text] [Related]
3. [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr mice]. Yang H, Xu A, Lv J, Liu Y. Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun 01; 32(6):821-5. PubMed ID: 22699062 [Abstract] [Full Text] [Related]
4. Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis. Fan X, Wüthrich RP. Inflammation; 1997 Feb 01; 21(1):105-12. PubMed ID: 9179626 [Abstract] [Full Text] [Related]
5. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A. Arthritis Rheum; 2002 Nov 01; 46(11):3083-95. PubMed ID: 12428253 [Abstract] [Full Text] [Related]
6. [Changes of the activity and expression of gamma-glutamylcysteine synthetase in patients with chronic obstructive pulmonary disease]. Lin SD, Dai AG, Xu P. Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb 01; 28(2):97-101. PubMed ID: 15854390 [Abstract] [Full Text] [Related]
7. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A. J Rheumatol; 2010 Jan 01; 37(1):60-70. PubMed ID: 19955044 [Abstract] [Full Text] [Related]
9. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U. J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217 [Abstract] [Full Text] [Related]
10. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR. J Immunol; 1998 Jul 01; 161(1):494-503. PubMed ID: 9647261 [Abstract] [Full Text] [Related]
11. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis. Wüthrich RP, Fan X, Ritthaler T, Sibalic V, Yu DJ, Loffing J, Kaissling B. Autoimmunity; 1998 Jul 01; 28(3):139-50. PubMed ID: 9867126 [Abstract] [Full Text] [Related]
12. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C. J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922 [Abstract] [Full Text] [Related]
13. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway. You Y, Qin Y, Lin X, Yang F, Li J, Sooranna SR, Pinhu L. BMC Nephrol; 2015 Aug 27; 16():148. PubMed ID: 26310926 [Abstract] [Full Text] [Related]
14. [Expression of BATF, a member of the activator protein-1 family, in renal tissues of MRL/lpr mice]. Peng Y, Li Q, Wang M, Cao C, Lai K, Zeng K. Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jun 27; 35(6):816-9. PubMed ID: 26111677 [Abstract] [Full Text] [Related]
15. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, Terada M, Hieshima K, Maruyama H, Miyazaki J, Yoshie O, Nose M, Fujita S. Arthritis Rheum; 2003 Sep 27; 48(9):2555-66. PubMed ID: 13130475 [Abstract] [Full Text] [Related]
16. Enhanced hyaluronan synthesis in the MRL-Fas(lpr) kidney: role of cytokines. Feusi E, Sun L, Sibalic A, Beck-Schimmer B, Oertli B, Wüthrich RP. Nephron; 1999 Sep 27; 83(1):66-73. PubMed ID: 10461038 [Abstract] [Full Text] [Related]
17. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice. Muraoka M, Hasegawa H, Kohno M, Inoue A, Miyazaki T, Terada M, Nose M, Yasukawa M. Arthritis Rheum; 2006 Nov 27; 54(11):3591-600. PubMed ID: 17075801 [Abstract] [Full Text] [Related]
18. Enhancement of gamma-glutamylcysteine synthetase mRNA in rat kidney by methyl mercury. Woods JS, Davis HA, Baer RP. Arch Biochem Biophys; 1992 Jul 27; 296(1):350-3. PubMed ID: 1351382 [Abstract] [Full Text] [Related]
19. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis. Rops AL, van den Hoven MJ, Bakker MA, Lensen JF, Wijnhoven TJ, van den Heuvel LP, van Kuppevelt TH, van der Vlag J, Berden JH. Nephrol Dial Transplant; 2007 Jul 27; 22(7):1891-902. PubMed ID: 17550924 [Abstract] [Full Text] [Related]
20. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice. Miyazaki T, Ono M, Qu WM, Zhang MC, Mori S, Nakatsuru S, Nakamura Y, Sawasaki T, Endo Y, Nose M. Eur J Immunol; 2005 May 27; 35(5):1510-20. PubMed ID: 15832294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]